PDT Partners’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.79M | Sell |
499,890
-159,150
| -24% | -$1.84M | 0.33% | 78 |
|
2025
Q1 | $5.75M | Buy |
659,040
+304,082
| +86% | +$2.65M | 0.41% | 46 |
|
2024
Q4 | $5.1M | Buy |
354,958
+226,513
| +176% | +$3.25M | 0.45% | 28 |
|
2024
Q3 | $2.9M | Sell |
128,445
-133,435
| -51% | -$3.01M | 0.26% | 126 |
|
2024
Q2 | $5.09M | Buy |
261,880
+216,662
| +479% | +$4.21M | 0.48% | 26 |
|
2024
Q1 | $1.7M | Sell |
45,218
-65,806
| -59% | -$2.47M | 0.16% | 225 |
|
2023
Q4 | $6.21M | Buy |
111,024
+18,077
| +19% | +$1.01M | 0.69% | 11 |
|
2023
Q3 | $3.83M | Buy |
92,947
+19,561
| +27% | +$807K | 0.48% | 36 |
|
2023
Q2 | $4.1M | Sell |
73,386
-109
| -0.1% | -$6.09K | 0.56% | 30 |
|
2023
Q1 | $4.1M | Buy |
+73,495
| New | +$4.1M | 0.56% | 14 |
|
2022
Q1 | – | Sell |
-27,573
| Closed | -$4.11M | – | 1125 |
|
2021
Q4 | $4.11M | Sell |
27,573
-8,227
| -23% | -$1.23M | 0.31% | 85 |
|
2021
Q3 | $5.21M | Buy |
35,800
+6,900
| +24% | +$1M | 0.37% | 53 |
|
2021
Q2 | $5.66M | Sell |
28,900
-7,300
| -20% | -$1.43M | 0.37% | 41 |
|
2021
Q1 | $6.55M | Sell |
36,200
-6,201
| -15% | -$1.12M | 0.47% | 12 |
|
2020
Q4 | $6M | Sell |
42,401
-23,121
| -35% | -$3.27M | 0.41% | 61 |
|
2020
Q3 | $8.17M | Sell |
65,522
-15,378
| -19% | -$1.92M | 0.54% | 31 |
|
2020
Q2 | $7.23M | Buy |
+80,900
| New | +$7.23M | 0.49% | 69 |
|